Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pilot Study to Evaluate Knee Osteoarthritis Outcome Measures in Arthritic Patients Prescribed Forteo or Prolia for Osteoporosis

Trial Profile

Pilot Study to Evaluate Knee Osteoarthritis Outcome Measures in Arthritic Patients Prescribed Forteo or Prolia for Osteoporosis

Status: Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 30 Oct 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Denosumab (Primary) ; Teriparatide (Primary)
  • Indications Osteoarthritis; Osteoporosis
  • Focus Biomarker; Proof of concept; Therapeutic Use
  • Most Recent Events

    • 22 Oct 2019 Status changed from not yet recruiting to withdrawn prior to enrolment.
    • 04 Apr 2019 Planned End Date changed from 31 Dec 2023 to 31 Dec 2024.
    • 04 Apr 2019 Planned primary completion date changed from 31 Dec 2022 to 31 Dec 2023.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top